The concerted roles of FANCM and Rad52 in the protection of common fragile sites

[1]  Jiadong Wang,et al.  BRCA2 antagonizes classical and alternative nonhomologous end-joining to prevent gross genomic instability , 2017, Nature Communications.

[2]  F. Jessen,et al.  Association Between Loss-of-Function Mutations Within the FANCM Gene and Early-Onset Familial Breast Cancer , 2017, JAMA oncology.

[3]  Sofia Khan,et al.  FANCM mutation c.5791C>T is a risk factor for triple-negative breast cancer in the Finnish population , 2017, Breast Cancer Research and Treatment.

[4]  F. Storici,et al.  Rad52 Inverse Strand Exchange Drives RNA-Templated DNA Double-Strand Break Repair. , 2017, Molecular cell.

[5]  Lara E Sucheston-Campbell,et al.  Germline whole exome sequencing and large-scale replication identifies FANCM as a likely high grade serous ovarian cancer susceptibility gene , 2017, Oncotarget.

[6]  J. Lukas,et al.  Mammalian RAD52 Functions in Break-Induced Replication Repair of Collapsed DNA Replication Forks , 2016, Molecular cell.

[7]  I. Hickson,et al.  RAD52 Facilitates Mitotic DNA Synthesis Following Replication Stress. , 2016, Molecular cell.

[8]  C. Schildkraut,et al.  FANCD2 Facilitates Replication through Common Fragile Sites. , 2016, Molecular cell.

[9]  Jeremy M. Stark,et al.  Regulation of Single-Strand Annealing and its Role in Genome Maintenance. , 2016, Trends in genetics : TIG.

[10]  B. Kerem,et al.  The complex nature of fragile site plasticity and its importance in cancer. , 2016, Current opinion in cell biology.

[11]  A. D’Andrea,et al.  The Fanconi anaemia pathway: new players and new functions , 2016, Nature Reviews Molecular Cell Biology.

[12]  P. Sung,et al.  Functions and regulation of the multitasking FANCM family of DNA motor proteins , 2015, Genes & development.

[13]  B. Kerem,et al.  Oncogenes create a unique landscape of fragile sites , 2015, Nature Communications.

[14]  M. Jasin,et al.  Homologous recombination and human health: the roles of BRCA1, BRCA2, and associated proteins. , 2015, Cold Spring Harbor perspectives in biology.

[15]  Rodney Rothstein,et al.  Mechanisms and Regulation of Mitotic Recombination in Saccharomyces cerevisiae , 2014, Genetics.

[16]  F. Couch,et al.  Exome sequencing identifies FANCM as a susceptibility gene for triple-negative breast cancer , 2014, Proceedings of the National Academy of Sciences.

[17]  Jing He,et al.  CtIP maintains stability at common fragile sites and inverted repeats by end resection-independent endonuclease activity. , 2014, Molecular cell.

[18]  Lei Li,et al.  Structure analysis of FAAP24 reveals single-stranded DNA-binding activity and domain functions in DNA damage response , 2013, Cell Research.

[19]  S. Powell,et al.  RAD52 inactivation is synthetically lethal with deficiencies in BRCA1 and PALB2 in addition to BRCA2 through RAD51-mediated homologous recombination , 2013, Oncogene.

[20]  Lei Li,et al.  FANCM and FAAP24 maintain genome stability via cooperative as well as unique functions. , 2013, Molecular cell.

[21]  S. Powell,et al.  Rad51 Paralog Complexes BCDX2 and CX3 Act at Different Stages in the BRCA1-BRCA2-Dependent Homologous Recombination Pathway , 2012, Molecular and Cellular Biology.

[22]  B. Kerem,et al.  The complex basis underlying common fragile site instability in cancer. , 2012, Trends in genetics : TIG.

[23]  Linda Z. Shi,et al.  CtIP Protein Dimerization Is Critical for Its Recruitment to Chromosomal DNA Double-stranded Breaks* , 2012, The Journal of Biological Chemistry.

[24]  B. Kerem,et al.  Failure of origin activation in response to fork stalling leads to chromosomal instability at fragile sites. , 2011, Molecular cell.

[25]  M. Jasin,et al.  Homology-directed Fanconi anemia pathway crosslink repair is dependent on DNA replication , 2011, Nature structural & molecular biology.

[26]  W. Heyer,et al.  Who's who in human recombination: BRCA2 and RAD52 , 2010, Proceedings of the National Academy of Sciences.

[27]  T. Pandita,et al.  Rad52 inactivation is synthetically lethal with BRCA2 deficiency , 2010, Proceedings of the National Academy of Sciences.

[28]  S. Kowalczykowski,et al.  Purified human BRCA2 stimulates RAD51-mediated recombination , 2010, Nature.

[29]  A. D’Andrea,et al.  The FANCM/FAAP24 complex is required for the DNA interstrand crosslink-induced checkpoint response. , 2010, Molecular cell.

[30]  P. Sung,et al.  MHF1-MHF2, a histone-fold-containing protein complex, participates in the Fanconi anemia pathway via FANCM. , 2010, Molecular cell.

[31]  Weidong Wang,et al.  A histone-fold complex and FANCM form a conserved DNA-remodeling complex to maintain genome stability. , 2010, Molecular cell.

[32]  R. Schwab,et al.  ATR activation and replication fork restart are defective in FANCM‐deficient cells , 2010, The EMBO journal.

[33]  K. Mrasek,et al.  New aspects on chromosomal instability: chromosomal break-points in Fanconi anemia patients co-localize on the molecular level with fragile sites. , 2009, International journal of oncology.

[34]  S. West,et al.  FANCM connects the genome instability disorders Bloom's Syndrome and Fanconi Anemia. , 2009, Molecular cell.

[35]  K. Eckert,et al.  DNA structure and the Werner protein modulate human DNA polymerase delta-dependent replication dynamics within the common fragile site FRA16D , 2009, Nucleic acids research.

[36]  H. Joenje,et al.  Fancm-deficient mice reveal unique features of Fanconi anemia complementation group M. , 2009, Human molecular genetics.

[37]  Bing Xia,et al.  Recruitment of fanconi anemia and breast cancer proteins to DNA damage sites is differentially governed by replication. , 2009, Molecular cell.

[38]  R. Rothstein,et al.  Rad52 , 2009, Current Biology.

[39]  I. Hickson,et al.  Replication stress induces sister-chromatid bridging at fragile site loci in mitosis , 2009, Nature Cell Biology.

[40]  S. Elledge,et al.  FANCM and FAAP24 function in ATR-mediated checkpoint signaling independently of the Fanconi anemia core complex. , 2008, Molecular cell.

[41]  A. Constantinou,et al.  Remodeling of DNA replication structures by the branch point translocase FANCM , 2008, Proceedings of the National Academy of Sciences.

[42]  Weidong Wang,et al.  FANCM of the Fanconi anemia core complex is required for both monoubiquitination and DNA repair. , 2008, Human molecular genetics.

[43]  A. Papavassiliou,et al.  Oncogene-induced replication stress preferentially targets common fragile sites in preneoplastic lesions. A genome-wide study , 2008, Oncogene.

[44]  A. Gurtan,et al.  Cell cycle-dependent chromatin loading of the Fanconi anemia core complex by FANCM/FAAP24. , 2008, Blood.

[45]  Xiaohua Wu,et al.  Cell Cycle-dependent Complex Formation of BRCA1·CtIP·MRN Is Important for DNA Double-strand Break Repair* , 2008, Journal of Biological Chemistry.

[46]  Andrzej Stasiak,et al.  The Fanconi anemia protein FANCM can promote branch migration of Holliday junctions and replication forks. , 2008, Molecular cell.

[47]  T. Glover,et al.  Chromosome fragile sites. , 2007, Annual review of genetics.

[48]  Weidong Wang.  Emergence of a DNA-damage response network consisting of Fanconi anaemia and BRCA proteins , 2007, Nature Reviews Genetics.

[49]  C. Freudenreich,et al.  An AT-rich sequence in human common fragile site FRA16D causes fork stalling and chromosome breakage in S. cerevisiae. , 2007, Molecular cell.

[50]  Xiaohua Wu,et al.  The Mre11 Complex Mediates the S-Phase Checkpoint through an Interaction with Replication Protein A , 2007, Molecular and Cellular Biology.

[51]  Bhuvanesh Singh,et al.  Downregulation of Fanconi Anemia Genes in Sporadic Head and Neck Squamous Cell Carcinoma , 2007, ORL.

[52]  S. West,et al.  Identification of FAAP24, a Fanconi anemia core complex protein that interacts with FANCM. , 2007, Molecular cell.

[53]  Aaron Bensimon,et al.  Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication , 2006, Nature.

[54]  Dimitris Kletsas,et al.  Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints , 2006, Nature.

[55]  J. Jonkers,et al.  Mouse models of BRCA1 and BRCA2 deficiency: past lessons, current understanding and future prospects , 2006, Oncogene.

[56]  T. Glover,et al.  Common fragile sites as targets for chromosome rearrangements. , 2006, DNA repair.

[57]  Anne E Carpenter,et al.  A Lentiviral RNAi Library for Human and Mouse Genes Applied to an Arrayed Viral High-Content Screen , 2006, Cell.

[58]  J. Pereira-Leal,et al.  The vertebrate Hef ortholog is a component of the Fanconi anemia tumor-suppressor pathway , 2005, Nature Structural &Molecular Biology.

[59]  T. Ørntoft,et al.  DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis , 2005, Nature.

[60]  Dimitris Kletsas,et al.  Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions , 2005, Nature.

[61]  A. D’Andrea,et al.  The Fanconi anemia pathway is required for the DNA replication stress response and for the regulation of common fragile site stability. , 2005, Human molecular genetics.

[62]  Zhao-Qi Wang,et al.  Human Fanconi anemia monoubiquitination pathway promotes homologous DNA repair. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[63]  M. Kastan,et al.  BRCA1 Is Required for Common-Fragile-Site Stability via Its G2/M Checkpoint Function , 2004, Molecular and Cellular Biology.

[64]  W. Hahn,et al.  Telomerase Maintains Telomere Structure in Normal Human Cells , 2003, Cell.

[65]  M. Jasin.  Homologous repair of DNA damage and tumorigenesis:the BRCA connection , 2002, Oncogene.

[66]  T. Glover,et al.  ATR Regulates Fragile Site Stability , 2002, Cell.

[67]  B. Morolli,et al.  Targeted Inactivation of Mouse RAD52Reduces Homologous Recombination but Not Resistance to Ionizing Radiation , 1998, Molecular and Cellular Biology.

[68]  S. Scherer,et al.  Molecular characterization of a common fragile site (FRA7H) on human chromosome 7 by the cloning of a simian virus 40 integration site. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[69]  P. Hasty,et al.  A mutation in mouse rad51 results in an early embryonic lethal that is suppressed by a mutation in p53 , 1996, Molecular and cellular biology.

[70]  K. Nakao,et al.  Targeted disruption of the Rad51 gene leads to lethality in embryonic mice. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[71]  T. Glover,et al.  FRA3B extends over a broad region and contains a spontaneous HPV16 integration site: direct evidence for the coincidence of viral integration sites and fragile sites. , 1996, Human molecular genetics.

[72]  B. Dutrillaux,et al.  Common fragile sites: mechanisms of instability revisited. , 2012, Trends in genetics : TIG.

[73]  J. Fryns,et al.  Human chromosome fragility. , 2008, Biochimica et biophysica acta.

[74]  Link,et al.  Mouse models of BRCA 1 and BRCA 2 deficiency : past lessons , current understanding and future prospects , 2022 .